Bio-pharma major Biocon on expansion mode.
Bio-pharma major Biocon is on an expansion mode. The biotech major plans to invest close to Rs 100 crore on its new research and development center located in Bangalore, with a window for future investments going up to Rs 200 crore in next few years.
Biocon is banking on a strong research pipeline. The company's focus on oral insulin will continue.
Biocon stock price
On November 24, 2014, at 15:08 hrs Biocon was quoting at Rs 458.15, up Rs 0.55, or 0.12 percent. The 52-week high of the share was Rs 553.70 and the 52-week low was Rs 364.15.
The company's trailing 12-month (TTM) EPS was at Rs 20.14 per share as per the quarter ended September 2014. The stock's price-to-earnings (P/E) ratio was 22.75. The latest book value of the company is Rs 120.89 per share. At current value, the price-to-book value of the company is 3.79.
Set email alert for
ADS BY GOOGLE
video of the day
India stays amid the best games in town: BNP's Raychaudhuri